Using a broad screening approach, Helming et al. identified ARID1B, an ARID1A homolog whose gene product is mutually exclusive with ARID1A in SWI/SNF complexes [8], as the preferentially required gene for the survival of ARID1A-mutant ovarian cancer cell lines. Here, ARID1A is linked to ovarian cancer.